In PRECIDENTD, we hope to learn which diabetes medications work best to reduce the risk of heart and kidneydisease in people with type 2 diabetes. People with type 2 diabetes are twice as likely to have heart disease or a stroke compared to someone who does not…
The purpose of this study is to determine how safe and effective using three medications (pegylated-interferon, ribavirin and boceprevir) are in curing HCV in patients with end stage kidneydisease on hemodialysis. Participants will be prescribed these three medications and will be followed…